Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT06624189

Active Choice Clinical Decision Support (CDS): Hepatocellular Carcinoma (HCC) Screening in Patients With Cirrhosis

The research team will evaluate the effectiveness of an auto-pended bot liver ultrasound order that will prompt providers at the time of encounter to place appropriate imaging orders for hepatocellular carcinoma (HCC) screening in patients with cirrhosis.

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Conditions

Hepatocellular Carcinoma Adenocarcinoma Carcinoma Carcinoma, Hepatocellular Cirrhosis Digestive System Diseases Digestive System Neoplasms Fibrosis Liver Diseases Liver Neoplasms Neoplasms Neoplasms by Histologic Type Neoplasms by Site Neoplasms, Glandular and Epithelial Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

NYU Langone Health

New York, 10016, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • cirrhosis diagnosis,
  • 6 months or more after since most recent imaging.

Exclusion criteria

  • previous liver transplant,
  • HCC diagnosis,
  • receiving hospice care,
  • completed external imaging in the past 6 months.

Treatment and study plan

Auto-pended bot liver ultrasound order

Other

This alert prompt providers at the time of encounter to place appropriate imaging orders for hepatocellular carcinoma (HCC) screening in patients with cirrhosis.

Primary outcomes

  1. Percentage of Participants for whom the Physician Completed Ordering of the Pending Liver Ultrasound

    Time frame: Day 1

Secondary outcomes

  1. Percentage of Participants with Completed Liver Ultrasound Imaging

    Time frame: Day 1

  2. HCC Diagnosis Rate from Completed Liver Ultrasound Imaging

    Time frame: Day 1

Sponsors and collaborators

Lead sponsor

NYU Langone Health

Other

Registry information

Official study title

Active Choice Clinical Decision Support: Hepatocellular Carcinoma Screening in Patients With Cirrhosis

Important dates

Study start
2024
Primary completion
2026
Study completion
2026
First posted
Oct 2, 2024
Registry last updated
Feb 27, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.